Key Indexing Terms
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to The American Journal of the Medical Sciences
- Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel III) final report.Circulation. 2002; 106: 3143-3421
- ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task force on practice guidelines.J Am Coll Cardiol. 2013; 2013
- Inclusion of stroke as an outcome and risk equivalent in risk scores for primary and secondary prevention of vascular disease.Circulation. 2010; 121: 2071-2078
- Inclusion of stroke in cardiovascular risk prediction instruments: a statement for healthcare professionals from the American Heart Association/American Stroke Association.Stroke. 2012; 43: 1998-2027
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).JAMA. 2001; 285: 2486-2497
- Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines.Circulation. 2004; 110: 227-239
- ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College ofCardiology/American Heart Association task force on practice guidelines.Circulation. 2013; 2013
- Benefit of intensive statin therapy in women: results from PROVE IT-TIMI 22.Circ Cardiovasc Qual Outcomes. 2011; 4: 328-336
- Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trial.JAMA. 2008; 299: 1678-1689
- Ten-year trends of cardiovascular drug use after myocardial infarction among community-dwelling persons>or=65 years of age.Am J Cardiol. 2007; 100: 1061-1067
- Use of global coronary heart disease risk assessment in practice: a cross-sectional survey of a sample of U.S. physicians.BMC Health Serv Res. 2012; 12: 20
- Trends in statin use and low-density lipoprotein cholesterol levels among U.S. adults: impact of the 2001 National Cholesterol Education Program guidelines.Ann Pharmacother. 2008; 42: 1208-1215
- Trends in the prevalence, awareness, treatment and control of high low density lipoprotein- cholesterol among United States adults from 1999–2000 through 2009–2010.Am J Cardiol. 2013; 112: 664-670
- The reasons for geographic and racial differences in stroke study: objectives and design.Neuroepidemiology. 2005; 25: 135-143
- A new equation to estimate glomerular filtration rate.Ann Intern Med. 2009; 150: 604-612
- K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.Am J Kidney Dis. 2002; 39: S1-S266
- National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification.Ann Intern Med. 2003; 139: 137-147
- Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.Clin Chem. 1972; 18: 499-502
- Multiple imputation using chained equations: issues and guidance for practice.Stat Med. 2011; 30: 377-399
- The NCDR ACTION Registry-GWTG: transforming contemporary acute myocardial infarction clinical care.Heart. 2010; 96: 1798-1802
- Automated outreach to increase primary adherence to cholesterol-lowering medications.JAMA Intern Med. 2013; 173: 38-43
- Adherence with statin therapy in elderly patients with and without acute coronary syndromes.JAMA. 2002; 288: 462-467
- Heart disease and stroke statistics-2013 update: a report from the American Heart Association.Circulation. 2013; 127: e6-e245
- Validation of the Framingham coronary heart disease prediction scores: results of a multiple Ethnic Groups Investigation.JAMA: The J Am Med Assoc. 2001; 286: 180-187
- National study of physician awareness and adherence to cardiovascular disease prevention guidelines.Circulation. 2005; 111: 499-510
Supported by grants R01 HL080477 (M.M.S., P.M. and C.M.G.) and K24 HL111154 (M.M.S. and C.M.G.), both from the National Heart Lung and Blood Institute (NHLBI); U01 NS041588 from the National Stroke Institute (NSI) (M.M.S. and P.M.); and K12 HS021694 (H.Y.) from the Agency for Healthcare Research and Quality (AHRQ). Investigator-initiated grant-in-aid from Amgen Pharmaceuticals, Inc. (P.M., M.M.S., M.L., R.R. and M.F.).
M. M. Safford reported consulting for diaDexus and receiving salary support from diaDexus. J. M. Woolley is employed by Amgen, Inc. R. Rosenson serves a consultant to Amgen, Inc, and the Mount Sinai School of Medicine receives research support from Amgen, Inc. P. Muntner reported serving on an Amgen advisory board; serving as a consultant to Amgen; and receiving grants from Amgen. The remaining authors have no financial or other conflicts of interest to disclose.
The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Neurological Disorders and Stroke or the National Institutes of Health. Representatives of the funding agencies have been involved in the review of the article but not directly involved in the collection, management, analysis, or interpretation of the data. Amgen did not have any role in the design and conduct of the study; in the collection, management, data analysis and interpretation of the data; or in the preparation or approval of the article.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.amjmedsci.com).